Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug;27(8):921-925.
doi: 10.1002/pds.4569. Epub 2018 Jun 3.

Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents

Michael L Jackson  1 , Onchee Yu  1 , Jennifer C Nelson  1 , James D Nordin  2 , Sara Y Tartof  3 , Nicola P Klein  4 , James G Donahue  5 , Stephanie A Irving  6 , Jason M Glanz  7 , Michael M McNeil  8 , Lisa A Jackson  1
Affiliations

Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents

Michael L Jackson et al. Pharmacoepidemiol Drug Saf. 2018 Aug.

Abstract

In light of waning immunity to pertussis following receipt of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine, maintaining protection may require repeated Tdap vaccination. We evaluated the safety of repeated doses of tetanus-containing vaccine in 68 915 nonpregnant adolescents and adults in the Vaccine Safety Datalink population who had received an initial dose of Tdap. Compared with 7521 subjects who received a subsequent dose of tetanus toxoid, reduced diphtheria (Td) vaccine, the 61 394 subjects who received a subsequent dose of Tdap did not have significantly elevated risk of medical visits for seizure, cranial nerve disorders, limb swelling, pain in limb, cellulitis, paralytic syndromes, or encephalopathy/encephalitis/meningitis. These results suggest that repeated Tdap vaccination has acceptable safety relative to Tdap vaccination followed by Td vaccination.

Keywords: pharmacoepidemiology; vaccination; whooping cough.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

MLJ has received research funding from Sanofi unrelated to the current project. The other authors report no conflicts of interest. The study sponsor participated in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the report for publication.

Figures

FIGURE 1
FIGURE 1
Adjusted* rate ratios of adverse events following toxoid and acellular pertussis (Tdap) vs Td as a second dose of tetanus-containing vaccine following an initial dose of Tdap, overall and stratified by years between vaccine doses*Overall risk ratios adjusted for age at first Tdap, years between first Tdap and second tetanus-containing vaccine, sex, study site, receipt of human papillomavirus vaccine, and hospitalizations in the prior year. Stratified risk ratios adjusted for age at first Tdap and years between first Tdap and second tetanus-containing vaccine.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR Morb Mortal Wkly Rep. 2011;60(1):13–15. - PubMed
    1. Broder KR, Cortese MM, Iskander JK, et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-3):1–34. - PubMed
    1. Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women–Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep. 2013;62(7):131–135. - PMC - PubMed
    1. Mertsola J, van der Meeren O, He Q, et al. Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults. Clin Infect Dis. 2010;51(6):656–662. - PubMed
    1. Koepke R, Eickhoff JC, Ayele RA, et al. Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand. J Infect Dis. 2014;210(6):942–953. - PubMed

Publication types

MeSH terms

Substances